CliffBio
small molecule

MIRALAX

POLYETHYLENE GLYCOL 3350

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameMIRALAX
Active ingredientPOLYETHYLENE GLYCOL 3350
Strength17GM/PACKET
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2006
Marketing statusOTC

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.